These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25943172)

  • 1. A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study.
    Motarjemizadeh Q; Aidenloo NS; Sepehri S
    Int Ophthalmol; 2016 Feb; 36(1):63-71. PubMed ID: 25943172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
    Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
    Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.
    Wu PC; Kuo HK; Tai MH; Shin SJ
    Cornea; 2009 Jan; 28(1):103-4. PubMed ID: 19092418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different doses of subconjunctival bevacizumab on the recurrence rate of excised primary pterygium.
    Razeghinejad R; Banifatemi M; Hosseini H
    Bull Soc Belge Ophtalmol; 2013; (322):13-20. PubMed ID: 24923077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.
    Singh P; Sarkar L; Sethi HS; Gupta VS
    Indian J Ophthalmol; 2015 Oct; 63(10):779-84. PubMed ID: 26655003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
    Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
    Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
    Fallah MR; Khosravi K; Hashemian MN; Beheshtnezhad AH; Rajabi MT; Gohari M
    Curr Eye Res; 2010 Jan; 35(1):17-22. PubMed ID: 20021250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
    Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
    Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.
    Rachmiel R; Leiba H; Levartovsky S
    Br J Ophthalmol; 1995 Mar; 79(3):233-6. PubMed ID: 7703200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
    Razeghinejad MR; Hosseini H; Ahmadi F; Rahat F; Eghbal H
    Ophthalmic Res; 2010; 43(3):134-8. PubMed ID: 19887878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab and ocular wound healing after primary pterygium excision.
    Banifatemi M; Razeghinejad MR; Hosseini H; Gholampour A
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):17-21. PubMed ID: 20977367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery.
    Amano S; Motoyama Y; Oshika T; Eguchi S; Eguchi K
    Br J Ophthalmol; 2000 Jun; 84(6):618-21. PubMed ID: 10837388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of subconjunctival bevacizumab for recurrent pterygium.
    Stival LR; Lago AM; Figueiredo MN; Bittar RH; Machado ML; Nassaralla Junior JJ
    Arq Bras Oftalmol; 2014; 77(1):4-7. PubMed ID: 25076364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporine A administration after pterygium surgery.
    Özülken K; Koç M; Ayar O; Hasiripi H
    Eur J Ophthalmol; 2012; 22 Suppl 7():S5-10. PubMed ID: 21725937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterygium excision using 193-nm excimer laser smoothing and topical mitomycin C.
    Seiler T; Schnelle B; Wollensak J
    Ger J Ophthalmol; 1992; 1(6):429-31. PubMed ID: 1490143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
    Enkvetchakul O; Thanathanee O; Rangsin R; Lekhanont K; Suwan-Apichon O
    Cornea; 2011 Nov; 30(11):1213-8. PubMed ID: 21915047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.